|
|
||||||||
Published online before print April 13, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,25-dihydroxyvitamin D3
,
*Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Roma, Italy; and
BioXell, Milano, Italy
@ To whom correspondence should be addressed. E-mail: gessani{at}iss.it.
| Abstract |
|---|
Interferon (IFN) regulatory factor (IRF)-4 is a lymphoid- and myeloid-restricted transcription factor of the IRF family. We analyzed its expression during differentiation of human monocytes along the macrophage or the dendritic cell (DC) pathway and in blood myeloid and plasmacytoid DC (M-DC and P-DC, respectively) subsets. Monocyte differentiation into DC, driven by granulocyte macrophage-colony stimulating factor (GM-CSF)/interleukin-4 or GM-CSF/IFN-
, resulted in a strong up-regulation of IRF-4 mRNA and protein, which was further increased by lipopolysaccharide. It is interesting that 1
,25-dihydroxyvitamin D3 [1,25(OH)2D3], a potent inhibitor of DC differentiation, completely abolished IRF-4 up-regulation. IRF-4 was also detected in blood P-DC and M-DC. However, up-regulation upon in vitro culture and down-regulation by 1,25(OH)2D3 was observed in M-DC but not in P-DC. These results point to IRF-4 as a potential player in human M-DC differentiation and as a novel target for the immunomodulatory activity of 1,25(OH)2D3.
Key Words: transcription factor immunomodulator gene regulation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |